iRay Group (SHA:688301)

Market Cap	43.49B +148.1%
Revenue (ttm)	2.46B +34.8%
Net Income	685.66M +46.2%
EPS	3.20 +38.8%
Shares Out	211.36M
PE Ratio	64.33
Forward PE	51.42
Dividend	1.00 (0.52%)
Ex-Dividend Date	Jun 19, 2025

Volume	10,222,631
Open	195.11
Previous Close	192.01
Day's Range	193.83 - 210.58
52-Week Range	83.55 - 209.38
Beta	0.41
Analysts	Buy
Price Target	137.82 (-33.02%)
Earnings Date	Aug 14, 2026

About iRay Group

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It also engages in technology and product development...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Employees: 2,292
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688301

Financial Performance

In 2025, iRay Group's revenue was 2.25 billion, an increase of 22.90% compared to the previous year's 1.83 billion. Earnings were 650.01 million, an increase of 39.73%.